Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NRF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NUDT3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MFSD7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PREP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELOVL5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CADM4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CSPP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RFPL1S - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
UNKL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LAMTOR5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELAC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
THAP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RCN3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BARD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMARCA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIK3R2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KMT2E-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBXN2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CAAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC9A5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on